{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:21:33Z","timestamp":1790612493561,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007554.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000}}],"reference-count":270,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007554.pub3","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T23:19:57Z","timestamp":1540509597000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Biocompatible dialysis fluids for peritoneal dialysis"],"prefix":"10.1002","volume":"2018","author":[{"given":"Htay","family":"Htay","sequence":"first","affiliation":[{"name":"Singapore General Hospital; Department of Renal Medicine; 20 College Street Singapore Singapore 169856"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; Ipswich Road Woolloongabba Queensland Australia 4102"},{"name":"University of Queensland; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J","family":"Wiggins","sequence":"additional","affiliation":[{"name":"The Alfred Hospital; Department of Renal Medicine; Prahan VIC Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V","family":"Badve","sequence":"additional","affiliation":[{"name":"St George Hospital; Department of Nephrology; Kogarah NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"},{"name":"Flinders University; College of Medicine and Public Health; Adelaide SA Australia 5001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"},{"name":"University of Bari; Department of Emergency and Organ Transplantation; Bari Italy"},{"name":"Diaverum; Medical Scientific Office; Lund Sweden"},{"name":"Diaverum Academy; Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeoungjee","family":"Cho","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; Ipswich Road Woolloongabba Queensland Australia 4102"},{"name":"University of Queensland; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfq357","article-title":"Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid","volume":"26","author":"Bajo","year":"2011","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/089686080602600120","article-title":"A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients","volume":"26","author":"Brown","year":"2006","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3747\/pdi.2013.00170","article-title":"Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial","volume":"35","author":"Cho","year":"2015","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2369-15-8","article-title":"Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients","volume":"15","author":"Cho","year":"2014","journal-title":"BMC Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2014.12.017","article-title":"Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial","volume":"65","author":"Howard","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2011121201","article-title":"Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes","volume":"23","author":"Johnson","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD007554.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1093\/ndt\/gfs314","article-title":"The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial","volume":"27","author":"Johnson","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3747\/pdi.2012.00052","article-title":"The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial","volume":"32","author":"Johnson","year":"2012","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2369-11-25","article-title":"Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function","volume":"11","author":"Johnson","year":"2010","journal-title":"BMC Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/089686080602600121","article-title":"A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients","volume":"26","author":"Woodrow","year":"2006","journal-title":"Peritoneal Dialysis International"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD007554.pub3-BIB0011|cit11","first-page":"473A","article-title":"Effect of low GDP fluid use on residual renal function in incident peritoneal dialysis patients over 24-month period [abstract no: F-PO1627]","volume":"19","author":"Kim","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD007554.pub3-BIB0012|cit12","first-page":"278A","article-title":"Clinical benefits of a low glucose degradation products solution in patients starting peritoneal dialysis: preliminary report [abstract no: TH-PO809]","volume":"17","author":"Kim","year":"2006","journal-title":"Journal of American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/ndt\/gfp054","article-title":"Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study","volume":"24","author":"Kim","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Abstracts","key":"10.1002\/14651858.CD007554.pub3-BIB0014|cit14","first-page":"518A","article-title":"Preserved residual renal function in incident peritoneal dialysis patients using low glucose degradation products solutions [abstract no: SA-PO796]","volume":"18","author":"Kim","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000342523","article-title":"Biocompatible peritoneal dialysis solution preserves residual renal function","volume":"36","author":"Kim","year":"2012","journal-title":"American Journal of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1177\/089686080802803s22","article-title":"Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet study)","volume":"28 Suppl 3","author":"Kim","year":"2008","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0017|cit17","first-page":"iii175","article-title":"Effect of biocompatible PD fluid on preservation of residual renal function in incident CAPD patients: two-year extended follow-up study [abstract no: SA418]","volume":"3","author":"Kim","year":"2010","journal-title":"NDT Plus"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub3-BIB0018|cit18","first-page":"203","article-title":"Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism [abstract]","volume":"11","author":"Bredie","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0020|cit19","first-page":"A11","article-title":"Effects on peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism [abstract]","volume":"58","author":"Bredie","year":"2001","journal-title":"Netherlands Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0019|cit20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/089686080102100308","article-title":"Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism","volume":"21","author":"Bredie","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/089686089801800604","article-title":"Clinical evaluation of a peritoneal dialysis solution with 33 mmol\/L bicarbonate","volume":"18","author":"Cancarini","year":"1998","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/089686080102100603","article-title":"Acidosis correction with a new 25 mmol\/l bicarbonate\/15 mmol\/l lactate peritoneal dialysis solution","volume":"21","author":"Carrasco","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3747\/pdi.2011.00279","article-title":"The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.[Erratum appears in Perit Dial Int. 2013 Sep-Oct;33(5):473-4]","volume":"33","author":"Cho","year":"2013","journal-title":"Peritoneal Dialysis International"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub3-BIB0024|cit24","first-page":"iv254","article-title":"The clinical impacts of novel peritoneal dialysis fluids (PDFs) with neutral pH and low glucose degradation product (GDP) concentration (Balance\u00ae) [abstract no: SP708]","volume":"21","author":"Choi","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/089686080802800214","article-title":"The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial","volume":"28","author":"Choi","year":"2008","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0026|cit26","first-page":"112A","article-title":"The clinical usefulness of peritoneal dialysis fluids (PDFs) with neutral pH and low glucose degradation product (GDP) Concentration-Balance\u00ae [abstract no: SA-FC138]","volume":"16","author":"Lee","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3747\/pdi.2010.00009","article-title":"The influence of bicarbonate\/lactate-buffered PD fluids on N\u0190-(carboxyethyl)lysine and N\u0190-(carboxymethyl)lysine in peritoneal effluent","volume":"31","author":"Cnossen","year":"2011","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/089686089701700111","article-title":"A randomized controlled trial of a bicarbonate- and a bicarbonate\/lactate-containing dialysis solution in CAPD.[Erratum appears in Perit Dial Int 1997 May-Jun;17(3):223 Note: Cancarinu GC [corrected to Cancarini GC]]","volume":"17","author":"Coles","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"12","key":"10.1002\/14651858.CD007554.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/ndt\/13.12.3165","article-title":"A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report","volume":"13","author":"Coles","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0272-6386(00)70309-X","article-title":"In vivo exposure to bicarbonate\/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function","volume":"35","author":"Mackenzie","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub3-BIB0031|cit31","first-page":"S408","article-title":"In vivo exposure to bicarbonate\/lactate-buffered PDF (TBL) improves ex vivo PMO function, compared to bicarbonate-(TB) or lactate-buffered PDF (PD4) [abstract]","volume":"3","author":"Topley","year":"1997","journal-title":"Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0032|cit32","first-page":"292A","article-title":"Long-term in vivo exposure to bicarbonate\/lactate dialysis fluid improves ex vivo peritoneal macrophage (PMO) TNFa secretion [abstract]","volume":"9","author":"Williams","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub3-BIB0033|cit33","first-page":"156A","article-title":"Increasing our understanding of the mechanism of action of icodextrin (ICO) [abstract no: F-PO407]","volume":"15","author":"Davies","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub3-BIB0034|cit34","first-page":"17","article-title":"Icodextrin improves fluid balance in PD patients [abstract no: O52]","volume":"17","author":"Davies","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/ndt\/gfn176","article-title":"Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange","volume":"23","author":"Davies","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0037|cit37","first-page":"632A","article-title":"Icodextrin improves fluid status in PD patients [abstract no: SU-PO798]","volume":"13","author":"Davies","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub3-BIB0038|cit38","first-page":"206A","article-title":"Cardiovascular and hemodynamic profile related to hypotensive effect long term of icodextrine (ICO) in CAPD patients [abstract]","volume":"11","author":"Paolo","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0039|cit39","first-page":"476A","article-title":"Decline of residual renal function (RRF) in peritoneal dialysis (PD) patients (pts) depends on uptake of carbonyl compounds (CC) from the peritoneal cavity: first data of a prospective clinical trial [abstract]","volume":"14","author":"Haag-Weber","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/ndt\/gfq087","article-title":"Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study","volume":"25","author":"Haag-Weber","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0041|cit41","first-page":"199A","article-title":"Treatment with low GDP solution (CAPD balance) is associated with an increase in effluent CA125 and a decrease in HA content: data from the multi centre European Balance Trial [abstract no: F-P0685]","volume":"13","author":"Mackenzie","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0042|cit42","first-page":"101","article-title":"Continuous treatment with low GDP solution (CAPD Balance\u00ae) is associated with an increase in effluent CA125 and a decrease in HA content: data from the Multicenter European Balance Trial [abstract]","volume":"22","author":"Mackenzie","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0043|cit43","first-page":"199A","article-title":"Reduced systemic AGE formation with a low GDP solution (CAPD balance): data from the multicentre European Balance Trial [abstract no: F-PO683]","volume":"13","author":"Williams","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","article-title":"The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane","volume":"66","author":"Williams","year":"2004","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ndt\/gfh013","article-title":"Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells","volume":"19","author":"Witowski","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ki.5002574","article-title":"Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function","volume":"73","author":"Fan","year":"2008","journal-title":"Kidney International"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ki.2011.244","article-title":"Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival","volume":"80","author":"Srivastava","year":"2011","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1046\/j.1523-1755.1998.00167.x","article-title":"Randomized long-term evaluation of bicarbonate-buffered CAPD solution","volume":"54","author":"Feriani","year":"1998","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0049|cit49","first-page":"414","article-title":"An open controlled randomized clinical trial with bicarbonate CAPD solutions: interim results [abstract]","volume":"5","author":"Feriani","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0050|cit50","first-page":"A253","article-title":"Long term safety and efficacy of bicarbonate buffered peritoneal dialysis solutions [abstract]","volume":"11","author":"Feriani","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007554.pub3-BIB0051|cit51","first-page":"S82","article-title":"Experiences with bicarbonate solutions in peritoneal dialysis","volume":"23","author":"Passlick-Deetjen","year":"1994","journal-title":"Nieren-und Hochdruckkrankheiten"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0052|cit52","first-page":"iii477","article-title":"Effects of bicavera (BV) dialysate for peritoneal dialysis on the epithelial-to-mesenchymal transition (EMT) of the mesothelial cell (MC) ex vivo [abstract]","volume":"3","author":"Fernandez Perpen","year":"2010","journal-title":"NDT Plus"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3747\/pdi.2010.00315","article-title":"Influence of bicarbonate\/low-GDP peritoneal dialysis fluid (Bicavera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells","volume":"32","author":"Fernandez-Perpen","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2004090793","article-title":"Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration","volume":"16","author":"Finkelstein","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub3-BIB0055|cit55","first-page":"214","article-title":"Biocompatibility pattern of neutral bicarbonate\/lactate buffered peritoneal dialysis solution in chronic APD patients - a prospective; randomized; cross over study [abstract no: M672]","volume":"18","author":"Fusshoeller","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD007554.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/ndt\/gfh326","article-title":"Biocompatibility pattern of a bicarbonate\/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study","volume":"19","author":"Fusshoeller","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0057|cit57","first-page":"41A","article-title":"Local and systemic effects of neutral pH, low GDP dialysate in CAPD patients [abstract no: SA-FC202]","volume":"13","author":"Do","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub3-BIB0058|cit58","first-page":"375A","article-title":"The effect of neutral pH, low GDPs dialysis solution on fluid, solute transport and edema control in CAPD patients [abstract no: SA-PO337]","volume":"15","author":"Do","year":"2004","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1177\/089686080802803s20","article-title":"The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis","volume":"28 Suppl 3","author":"Do","year":"2008","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080502503S06","article-title":"The effect of low glucose degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients","volume":"25 Suppl 3","author":"Do","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub3-BIB0061|cit61","first-page":"479A","article-title":"Effects of low glucose degradation products (GDPs) dialysis solution on the levels of surrogate markers of peritoneal inflammation, integrity and angiogenesis. Preliminary report [abstract no: SA-PO822]","volume":"14","author":"Kim","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1046\/j.1440-1797.8.s.6.x","article-title":"Low glucose degradation products dialysis solution modulates the levels of surrogate markers of peritoneal inflammation, integrity, and angiogenesis: preliminary report","volume":"8 Suppl","author":"Kim","year":"2003","journal-title":"Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub3-BIB0063|cit63","first-page":"374A","article-title":"The effect of low GDPs solution on peritoneal fibrosis markers [abstract no: SA-PO333]","volume":"15","author":"Park","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1046\/j.1523-1755.2003.00887.x","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study","volume":"63","author":"Konings","year":"2003","journal-title":"Kidney International"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0065|cit65","first-page":"206A","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters [abstract no: F-PO719]","volume":"13","author":"Konings","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/089686080502500616","article-title":"Influence of icodextrin on plasma and dialysate levels of N\u0190-(carboxymethyl)lysine and N\u0190-(carboxyethyl)lysine","volume":"25","author":"Konings","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/089686080602600322","article-title":"The increase in plasma levels of N\u0190-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1","volume":"26","author":"Kooman","year":"2006","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3747\/pdi.2010.00176","article-title":"A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products","volume":"32","author":"Lai","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"11","key":"10.1002\/14651858.CD007554.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.02950509","article-title":"Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid","volume":"4","author":"Lin","year":"2009","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1523-1755.1998.00849.x","article-title":"Bicarbonate and bicarbonate\/lactate peritoneal dialysis solutions for the treatment of infusion pain","volume":"53","author":"Mactier","year":"1998","journal-title":"Kidney International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0071|cit71","first-page":"273A","article-title":"Treatment of infusion pain (InP) with novel bicarbonate containing PD solutions [abstract]","volume":"8","author":"Sprosen","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0072|cit72","first-page":"A240","article-title":"Reduction in the prevalence of CAPD symptoms during 6 months treatment with icodextrin [abstract]","volume":"11","author":"Armstrong","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/089686089501500309","article-title":"Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis","volume":"15","author":"Gokal","year":"1995","journal-title":"Peritoneal Dialysis International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0074|cit74","first-page":"283A","article-title":"Improvement of hyperlipidemia with icodextrin use in CAPD patients [abstract]","volume":"9","author":"Gokal","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ki.1994.300","article-title":"A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis","volume":"46","author":"Mistry","year":"1994","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ndt\/gfn673","article-title":"Short-term effects of bicarbonate\/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study","volume":"24","author":"Pajek","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/089686080802800109","article-title":"Short-term effects of a new bicarbonate\/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study","volume":"28","author":"Pajek","year":"2008","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1744-9987.2009.00717.x","article-title":"Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions","volume":"14","author":"Pajek","year":"2010","journal-title":"Therapeutic Apheresis & Dialysis"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3747\/pdi.2012.00279","article-title":"Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis","volume":"34","author":"Orihuela","year":"2014","journal-title":"Peritoneal Dialysis International"},{"issue":"108","key":"10.1002\/14651858.CD007554.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1038\/sj.ki.5002613","article-title":"Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis","volume":"73","author":"Paniagua","year":"2008","journal-title":"Kidney International - Supplement"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients","volume":"29","author":"Paniagua","year":"2009","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ndt\/gfr451","article-title":"Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study","volume":"27","author":"Park","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/ajkd.2002.32009","article-title":"Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis","volume":"39","author":"Plum","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/089686089701702S13","article-title":"Icodextrin plus glucose combinations for use in CAPD","volume":"17 Suppl 2","author":"Peers","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/089686080002000203","article-title":"Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years","volume":"20","author":"Posthuma","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/089686089901900409","article-title":"Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients","volume":"19","author":"Posthuma","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0096|cit87","first-page":"A184","article-title":"Icodextrin (I) use in CCPD patients during peritonitis: serum disaccharide levels and ultrafiltration (UF) [abstract]","volume":"12","author":"Posthuma","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0087|cit88","first-page":"223A","article-title":"Ex vivo peritoneal defense characteristics and peritonitis rate in CCPD patients using glucose or icodextrin as daytime dwell [abstract]","volume":"9","author":"Posthuma","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0088|cit89","first-page":"513","article-title":"Disaccharide (\"total maltose\") levels in CCPD patients using icodextrin [abstract]","volume":"6","author":"Posthuma","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0089|cit90","first-page":"S106","article-title":"Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group","volume":"20 Suppl 2","author":"Posthuma","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0090|cit91","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/089686089701700613","article-title":"Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell","volume":"17","author":"Posthuma","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0091|cit92","first-page":"270A","article-title":"Icodextrin (I) use in CCPD patients during peritonitis: serum disaccharide (maltose) levels and ultrafiltration (UF) [abstract]","volume":"8","author":"Posthuma","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0092|cit93","first-page":"513","article-title":"Improved ultrafiltration in CCPD patients using icodextrin (I) instead of glucose (G) for the long daytime dwell [abstract]","volume":"6","author":"Posthuma","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0093|cit94","first-page":"223A","article-title":"Peritoneal membrane characteristics in CCPD patients using glucose or icodextrin as daytime dwell [abstract]","volume":"9","author":"Posthuma","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0094|cit95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/089686080102100107","article-title":"Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin","volume":"21","author":"Posthuma","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0095|cit96","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/12.3.550","article-title":"Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance","volume":"12","author":"Posthuma","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/ndt\/13.9.2341","article-title":"Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations","volume":"13","author":"Posthuma","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0098|cit98","first-page":"A180","article-title":"More Ca125 in dialysate after long-term treatment with a new, less toxic PD-fluid (PD-bio) [abstract]","volume":"12","author":"Rippe","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0099|cit99","first-page":"182A","article-title":"Patient dialysate CA 125 and hyaluronan (HA) after 1, 6 and 12 months of treatment with a PD-fluid containing less cytotoxic glucose degradation products [abstract]","volume":"8","author":"Rippe","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1523-1755.2001.00497.x","article-title":"Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products","volume":"59","author":"Rippe","year":"2001","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0102|cit101","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1177\/089686080102103S20","article-title":"Biologic significance of reduced levels of glucose degradation products","volume":"21 Suppl 3","author":"Rippe","year":"2001","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0101|cit102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000071423","article-title":"Long-term results with low glucose degradation product content in peritoneal dialysis fluids","volume":"140","author":"Rippe","year":"2003","journal-title":"Contributions to Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0103|cit103","first-page":"322A","article-title":"Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products [abstract]","volume":"10","author":"Simonsen","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD007554.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1097\/01.ASN.0000086475.83211.DF","article-title":"Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis","volume":"14","author":"Haas","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl","key":"10.1002\/14651858.CD007554.pub3-BIB0105|cit105","first-page":"C53","article-title":"Randomized cross-over evaluation of bicarbonate-vs lactate buffered PD solutions in children on APD [abstract]","volume":"17","author":"Haas","year":"2002","journal-title":"Pediatric Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0106|cit106","first-page":"202A","article-title":"Better biocompatibility and correction of acidosis using bicarbonate vs lactate buffered PD fluid in children on APD: a randomized cross-over clinical trial [abstract]","volume":"13","author":"Haas","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 12","key":"10.1002\/14651858.CD007554.pub3-BIB0107|cit107","first-page":"17","article-title":"Randomized cross-over administration of pH-neutral, bicarbonate buffered PD solution in children on APD [abstract no: O51]","volume":"17","author":"Schmitt","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0108|cit108","first-page":"193A","article-title":"Comparison of solute and acid-base transport kinetics in children using bicarbonate- vs. lactate-buffered PD solutions [abstract]","volume":"9","author":"Schmitt","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1046\/j.1523-1755.2002.00255.x","article-title":"Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children","volume":"61","author":"Schmitt","year":"2002","journal-title":"Kidney International"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub3-BIB0110|cit110","first-page":"210","article-title":"Peritoneal dialysis (PD) solution with reduced glucose degradation product (GPD) content lowers serum concentrations of advanced glycated endproducts (AGE) in children on automated PD [abstract]","volume":"18","author":"Schmitt","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/ndt\/gfm148","article-title":"Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content","volume":"22","author":"Schmitt","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD007554.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/gfv247","article-title":"Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH)","volume":"30","author":"Moraes","year":"2015","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0113|cit113","first-page":"112A","article-title":"Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation-product - a randomized control trial [abstract no: SA-FC137]","volume":"16","author":"Szeto","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/gfl559","article-title":"Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial","volume":"22","author":"Szeto","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD007554.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"e0141425","DOI":"10.1371\/journal.pone.0141425","article-title":"The effect of neutral peritoneal dialysis solution with low glucose-degradation-product on the fluid status and body composition--a randomized control trial","volume":"10","author":"Szeto","year":"2015","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0116|cit116","unstructured":"Akagi S Sugiyama H Takatori Y Takiue K Inoue J Kojo S Effect of icodextrin on the fluid status in diabetic peritoneal dialysis patients - an interim report [abstract no: SA443] World Congress of Nephrology; 2009 May 22-26; Milan, Italy 2009"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.10041110","article-title":"Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial","volume":"6","author":"Takatori","year":"2011","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1177\/089686080102103S17","article-title":"Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate\/lactate-based peritoneal dialysis solutions","volume":"21 Suppl 3","author":"Cooker","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0119|cit119","first-page":"264A","article-title":"Bicarbonate\/lactate-buffered (TBL) peritoneal dialysis fluid (PDF) decreases pro-collagen I levels in peritoneal dialysis effluent (PDE) [abstract no: A1214]","volume":"8","author":"Holmes","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1523-1755.2001.0590041529.x","article-title":"Bicarbonate\/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels","volume":"59","author":"Jones","year":"2001","journal-title":"Kidney International"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1681\/ASN.V13suppl_1s97","article-title":"Continuous dialysis with bicarbonate\/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function","volume":"13","author":"Jones","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0122|cit122","first-page":"266A","article-title":"A long term study of a bicarbonate-lactate based peritoneal dialysis solution [abstract]","volume":"10","author":"O'Donoghue","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0123|cit123","first-page":"230A","article-title":"Peritoneal dialysate ca125, hyaluronan (ha), tgf\u00e11 and pro-collagen i peptide (picp) in a randomized, controlled study of bicarbonate\/lactate based CAPD solution [abstract]","volume":"10","author":"Toley","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0124|cit124","first-page":"290A","article-title":"In vivo exposure to bicarbonate\/lactate-buffered (TBL) peritoneal dialysis fluid (PDF) decreases pro-collagen I and TGF-b1 (TGF-b1) levels in peritoneal dialysis effluent (PDE) [abstract]","volume":"9","author":"Topley","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0125|cit125","first-page":"230A","article-title":"Peritoneal dialysate CA125, hyaluronan (HA), TGFb1 and pro-collagen I peptide (PICP) in a randomized, controlled study of bicarbonate\/lactate based CAPD solution. [abstract no: A1169]","volume":"10","author":"Topley","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/089686080002000506","article-title":"A long-term study of a bicarbonate\/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate\/Lactate Study Group","volume":"20","author":"Tranaeus","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3747\/pdi.2015.00090","article-title":"The Trio Trial - a randomized controlled clinical trial evaluating the effect of a biocompatible peritoneal dialysis solution on residual renal function","volume":"36","author":"Sikaneta","year":"2016","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/089686080902900610","article-title":"Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution","volume":"29","author":"Weiss","year":"2009","journal-title":"Peritoneal Dialysis International"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub3-BIB0129|cit129","first-page":"667","article-title":"Quality of life of peritoneal dialysis patients on icodextrin: a longitudinal study [abstract]","volume":"11","author":"Guo","year":"2002","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1046\/j.1523-1755.62.s81.10.x","article-title":"Early quality of life benefits of icodextrin in peritoneal dialysis","volume":"81","author":"Guo","year":"2002","journal-title":"Kidney International - Supplement"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0131|cit131","first-page":"317A","article-title":"One year results-icodextrin vs dextrose for the long dwell in peritoneal dialysis [abstract]","volume":"12","author":"Wolfson","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub3-BIB0132|cit132","first-page":"317A","article-title":"Effects of icodextrin on ultrafiltration (UF) and small solute clearance in continuous ambulatory dialysis patients (CAPD) [abstract]","volume":"12","author":"Wolfson","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/ajkd.2002.36344","article-title":"A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis","volume":"40","author":"Wolfson","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3747\/pdi.2013.00284","article-title":"Is It beneficial to convert to a neutral-pH bicarbonate\/lactate-buffered PD solution in long-term CAPD patients? A single-center prospective study","volume":"35","author":"Yoo","year":"2015","journal-title":"Peritoneal Dialysis International"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub3-BIB0135|cit135","first-page":"223A","article-title":"Resorption of age-promoting glucose degradation products (GDP) from peritoneal dialysis (PD) fluids leads to increased levels of age in plasma [abstract]","volume":"11","author":"Zeier","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1523-1755.2003.00705.x","article-title":"Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?","volume":"63","author":"Zeier","year":"2003","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2369-5-14","article-title":"BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]","volume":"5","author":"Nau","year":"2004","journal-title":"BMC Nephrology"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD007554.pub3-BIB0138|cit138","first-page":"696A","article-title":"BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [abstract no: SU-PO519]","volume":"18","author":"Schmitt","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2215\/CJN.00690112","article-title":"Effect of the dialysis fluid buffer on peritoneal membrane function in children","volume":"8","author":"Schmitt","year":"2013","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ndt\/gfn452","article-title":"Citrate supplementation of PD fluid: effects on net ultrafiltration and clearance of small solutes in single dwells","volume":"24","author":"Braide","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"13","key":"10.1002\/14651858.CD007554.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"e2991","DOI":"10.1097\/MD.0000000000002991","article-title":"Effect of icodextrin solution on the preservation of residual renal function in peritoneal dialysis patients: a randomized controlled study","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/gfu033","article-title":"Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis","volume":"29","author":"Chow","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Abstracts","key":"10.1002\/14651858.CD007554.pub3-BIB0143|cit143","first-page":"279A","article-title":"Effect of biocompatible peritoneal dialysis on transport status: the nutrineal, extraneal, physioneal (NEP) study [abstract no: TH-PO812]","volume":"17","author":"Coester","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/089686080402400613","article-title":"Enhanced ultrafiltration using 7.5% icodextrin\/1.36% glucose combination dialysate: a pilot study","volume":"24","author":"Dallas","year":"2004","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0272-6386(12)80270-8","article-title":"Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid","volume":"21","author":"Fijter","year":"1993","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0146|cit146","first-page":"978","article-title":"Glucose polymers as osmotic agent in CAPD fluids: a more favorable effect on peritoneal macrophage (PMO) function than glucose-based solutions [abstract]","volume":"40","author":"Fijter","year":"1991","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0147|cit147","unstructured":"Bargman JM Culleton BF Do JY Gomez RA Yu AW Prichard SS The impact of a low glucose peritoneal dialysis solution regimen on serum lipids and lipoproteins in diabetic patients: The IMPENDIA and EDEN randomized, controlled clinical trials [abstract no: FR-OR027] Journal of the American Society of Nephrology 2012 37A"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0148|cit148","doi-asserted-by":"crossref","unstructured":"Li PK Culleton BF Ariza A Do JY Johnson DW Sanabria M Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients Journal of the American Society of Nephrology 2013 1889 900 23949801","DOI":"10.1681\/ASN.2012100987"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0149|cit149","doi-asserted-by":"crossref","unstructured":"Sniderman AD Sloand JA Li PK Story K Bargman JM Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA\/EDEN trials Journal of Clinical Lipidology 2014 441 7 25110226","DOI":"10.1016\/j.jacl.2014.03.007"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/089686080802800108","article-title":"Comparison between bicarbonate\/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study","volume":"28","author":"Fang","year":"2008","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1177\/089686089301302S22","article-title":"Continuous ambulatory peritoneal dialysis with bicarbonate buffer--a pilot study","volume":"13 Suppl 2","author":"Feriani","year":"1993","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/089686089301300406","article-title":"Short-term clinical study with bicarbonate-containing peritoneal dialysis solution","volume":"13","author":"Feriani","year":"1993","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/ndt\/gfg518","article-title":"Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children","volume":"19","author":"Fischbach","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub3-BIB0154|cit154","first-page":"i437","article-title":"Randomised prospective clinical study on outcome of peritoneal dialysis in patients using normal versus reduced glucose dialysis solution [abstract]","volume":"28","author":"Hiss","year":"2013","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/joneph\/19.6.758","article-title":"Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions","volume":"19","author":"Hwang","year":"2006","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0156|cit156","unstructured":"Bargman JM Culleton BF Do JY Gomez RA Yu AW Prichard SS The impact of a low glucose peritoneal dialysis solution regimen on serum lipids and lipoproteins in diabetic patients: The IMPENDIA and EDEN randomized, controlled clinical trials [abstract no: FR-OR027] Journal of the American Society of Nephrology 2012 37A"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0157|cit157","doi-asserted-by":"crossref","unstructured":"Li PK Culleton BF Ariza A Do JY Johnson DW Sanabria M Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients Journal of the American Society of Nephrology 2013 1889 900 23949801","DOI":"10.1681\/ASN.2012100987"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0158|cit158","doi-asserted-by":"crossref","unstructured":"Li PK Dorval M Johnson DW Rutherford P Shutov E Story K The benefit of a glucose-sparing PD therapy on glycemic control measured by serum fructosamine in diabetic patients in a randomized, controlled trial (IMPENDIA) Nephron 2015 233 40 25766261","DOI":"10.1159\/000371554"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0159|cit159","doi-asserted-by":"crossref","unstructured":"Sniderman AD Sloand JA Li PK Story K Bargman JM Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA\/EDEN trials Journal of Clinical Lipidology 2014 441 7 25110226","DOI":"10.1016\/j.jacl.2014.03.007"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0160|cit160","first-page":"114","article-title":"Sodium and water clearance during peritoneal dwells with a novel combination dialysate (1.36% glucose\/7.5% Icodextrin) [abstract]","volume":"22","author":"Jenkins","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/089686080302300513","article-title":"An exploratory study of a novel peritoneal combination dialysate (1.36% glucose\/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone","volume":"23","author":"Jenkins","year":"2003","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1038\/sj.ki.5002612","article-title":"Effects of peritoneal dialysis fluid biocompatibility on baroreflex sensitivity","volume":"108","author":"John","year":"2008","journal-title":"Kidney International - Supplement"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub3-BIB0163|cit163","first-page":"478A","article-title":"PD regimen contributes to the blood concentration of glucose degradation products (GDP) in new CAPD patients [abstract no: SA-PO820]","volume":"14","author":"Poole","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD007554.pub3-BIB0164|cit164","first-page":"476a","article-title":"Biocompatibility markers of standard versus high-glucose regimen of CAPD patients in a multi-centered, cross-over study [abstract no: SA-PO812]","volume":"14","author":"Welten","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub3-BIB0165|cit165","first-page":"214","article-title":"The effects of a high-versus low-glucose regime on cell recruitment and biomarkers of CAPD patients. A multi-center, prospective cross-over study [abstract]","volume":"18","author":"Welten","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0166|cit166","first-page":"111","article-title":"Biocompatibility of high versus low glucose regime on peritoneal cells of CAPD patients in a multicenter cross-over study [abstract]","volume":"22","author":"Welten","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0167|cit167","first-page":"202A","article-title":"Biocompatibility of high- versus low-glucose regime on peritoneal cells of CAPD patients in a multi-centered cross-over study [abstract no: F-PO698]","volume":"13","author":"Welten","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0168|cit168","first-page":"200A","article-title":"Clinical effects of a PD regimen low in glucose and GDP's (LG) compared to a standard PD regimen (SPD) in newly CAPD patients [abstract no: F-PO688]","volume":"13","author":"Poole","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0169|cit169","first-page":"200A","article-title":"Outcome of routine laboratory data after 30 weeks of treatment with a PD regimen low in glucose and GDPs (LG) or a standard PD regimen (SPD) in newly CAPD patients [abstract no: F-PO689]","volume":"13","author":"Poole","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3747\/pdi.2012.00097","article-title":"Higher plasma levels of von Willebrand factor and C-reactive protein during a peritoneal dialysis regimen with less glucose and glucose degradation products","volume":"33","author":"Poole","year":"2013","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1177\/089686080502503S16","article-title":"Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious","volume":"25 Suppl 3","author":"Poole","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3747\/pdi.2010.00115","article-title":"A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation","volume":"32","author":"Poole","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub3-BIB0173|cit173","first-page":"375A","article-title":"Peritoneal dialysis regimen low in glucose and GDPs results in lower plasma pentosidine levels [abstract no: SA-PO338]","volume":"15","author":"Poole","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3747\/pdi.2010.00101","article-title":"\"NEPP\" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO","volume":"32","author":"Poole","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub3-BIB0176|cit175","first-page":"478A","article-title":"Clinical effects of PD regimens high or low in glucose and GDP's in a one year multi-center randomized cross-over trial [abstract no: SA-PO819]","volume":"14","author":"Poole","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub3-BIB0175|cit176","first-page":"159A","article-title":"Higher markers of endothelial activation during treatment with an alternative peritoneal dialysis solution regimen low in glucose and GDPs (NEPP) [abstract no: F-PO423]","volume":"15","author":"Poole","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub3-BIB0177|cit177","first-page":"478A","article-title":"Metabolic effects of PD regimens high or low in glucose and GDP's in a one year multi-center randomized cross-over trial [abstract no: SA-PO818]","volume":"14","author":"Poole","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0178|cit178","first-page":"170","article-title":"Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study","volume":"20","author":"Poole","year":"2004","journal-title":"Advances in Peritoneal Dialysis"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0179|cit179","first-page":"110A","article-title":"Low glucose\/GDP dialysis regimen results in increased mesothelial regeneration and vascular permeability [abstract no: SA-FC129]","volume":"16","author":"Ittersum","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/089686080202200604","article-title":"Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid","volume":"22","author":"Liberek","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007554.pub3-BIB0181|cit181","first-page":"ii460","article-title":"Effect of biocompatible peritoneal dialysis fluids on daily urine volume, serum adiponectin levels, small solute permeability and mesothelial cell integrity six months after conversion back to conventional peritoneal dialysis fluids [abstract]","volume":"27","author":"Lui","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2012.05.018","article-title":"A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial","volume":"60","author":"Lui","year":"2012","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3747\/pdi.2014.00125","article-title":"Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers","volume":"35","author":"Yung","year":"2015","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/089686080502500509","article-title":"Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?","volume":"25","author":"Martikainen","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/089686080702700617","article-title":"Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?","volume":"27","author":"Parikova","year":"2007","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000183338","article-title":"Acetate versus lactate in peritoneal dialysis solutions","volume":"39","author":"Pedersen","year":"1985","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/089686089701702S13","article-title":"Icodextrin plus glucose combinations for use in CAPD","volume":"17 Suppl 2","author":"Peers","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/089686089901900504","article-title":"An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose\/bicarbonate and glucose\/lactate solutions: an intraindividual randomized study","volume":"19","author":"Plum","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"8","key":"10.1002\/14651858.CD007554.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/ndt\/12.8.1652","article-title":"In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines\/prostanoids dialysate concentrations","volume":"12","author":"Plum","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub3-BIB0190|cit190","first-page":"S80","article-title":"Effects of alternative peritoneal dialysis solutions on peritoneal transport and cytokines\/prostanoids dialysate concentrations","volume":"26","author":"Plum","year":"1997","journal-title":"Nieren-und Hochdruckkrankheiten"},{"issue":"Abstracts","key":"10.1002\/14651858.CD007554.pub3-BIB0191|cit191","first-page":"278A","article-title":"Icodextrin-based nocturnal automated peritoneal dialysis (APD) allows sustained ultrafiltration (UF) while reducing peritoneal glucose load. A crossover study [abstract no: TH-PO806]","volume":"17","author":"Perez-Fontan","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/089686080702700310","article-title":"Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study","volume":"27","author":"Rodriguez-Carmona","year":"2007","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/089686080902900411","article-title":"Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis","volume":"29","author":"Sav","year":"2009","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0194|cit194","unstructured":"Sav T Oymak O Sipahioglu H Unal A Akcakaya M Tokgoz B The double dose icodextrin use can decrease the risk of the coronary heart disease in patients on peritoneal dialysis [abstract no: S-PO-0223] 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil 2007 108"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD007554.pub3-BIB0195|cit195","first-page":"vi299","article-title":"Double dose icodextrin not affect the peritoneal and systemic inflammation [abstract no: SaP201]","volume":"22","author":"Sav","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1440-1797.2009.01186.x","article-title":"Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients","volume":"15","author":"Sav","year":"2010","journal-title":"Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD007554.pub3-BIB0197|cit197","first-page":"v340","article-title":"Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin [abstract no: MP420]","volume":"20","author":"Selby","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/ndt\/gfh946","article-title":"Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin","volume":"20","author":"Selby","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfl654","article-title":"The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids","volume":"22","author":"Selby","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0200|cit200","first-page":"A182","article-title":"Peritoneal permeability characteristics using glycerol based dialysate in CAPD [abstract]","volume":"12","author":"Smit","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/089686080002000511","article-title":"Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis","volume":"20","author":"Smit","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/089686080002000626","article-title":"A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function","volume":"20","author":"Smit","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub3-BIB0203|cit203","first-page":"219A","article-title":"A comparison between 1.36% and 3.86% glucose dialysis solutions for the assessment of peritoneal membrane function [abstract no: A1160]","volume":"11","author":"Smit","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0204|cit204","first-page":"A233","article-title":"A comparison between 1.36% and 3.86% glucose dialysis solutions for the assessment of peritoneal membrane function [abstract]","volume":"15","author":"Smit","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1046\/j.1523-1755.2000.00436.x","article-title":"Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids","volume":"58","author":"Ueda","year":"2000","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/089686080402400304","article-title":"A randomized clinical trial with a 0.6% amino acid\/ 1.4% glycerol peritoneal dialysis solution","volume":"24","author":"Biesen","year":"2004","journal-title":"Peritoneal Dialysis International"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub3-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3747\/pdi.2012.00347","article-title":"The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study","volume":"34","author":"Yehia","year":"2014","journal-title":"Peritoneal Dialysis International"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3346\/jkms.2014.29.9.1217","article-title":"Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients","volume":"29","author":"Yoon","year":"2014","journal-title":"Journal of Korean Medical Science"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0209|cit209","first-page":"iii166","article-title":"The effect of low GDP solution on ultrafiltration and solute transport in CAPD patients [abstract]","volume":"3","author":"Cho","year":"2010","journal-title":"NDT Plus"},{"issue":"40","key":"10.1002\/14651858.CD007554.pub3-BIB0210|cit210","first-page":"2843","article-title":"Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients","volume":"90","author":"Dai","year":"2010","journal-title":"Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3747\/pdi.2015.00010","article-title":"Effect of balance solution on the peritoneal membrane in automated peritoneal dialysis","volume":"36","author":"Rios","year":"2016","journal-title":"Peritoneal Dialysis International"},{"issue":"Abstracts","key":"10.1002\/14651858.CD007554.pub3-BIB0212|cit212","first-page":"411A","article-title":"The effect of low GDPs solution on survival in continuous ambulatory peritoneal dialysis patients and the associated factors with survival [abstract no: F-PO347]","volume":"17","author":"Do","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub3-BIB0213|cit213","first-page":"208A","article-title":"Ca125\/pai-1 ration as a marker of biocompatibility in CAPD: a prospective randomized clinical trial [abstract]","volume":"11","author":"Gesualdo","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0214|cit214","first-page":"A238","article-title":"Ca125\/pai-1 ration may be a marker of peritoneal dialysis (PD) fluids biocompatibility and membrane longevity: a clinical randomized prospective study [abstract]","volume":"15","author":"Infante","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub3-BIB0215|cit215","first-page":"iv253","article-title":"Clinical benefits of a bicarbonate\/lactate-based peritoneal dialysis solution [abstract no: SP706]","volume":"21","author":"Kim","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2169\/internalmedicine.54.2763","article-title":"Effects of dialysis solution on the cardiovascular function in peritoneal dialysis patients","volume":"54","author":"Kocyigit","year":"2015","journal-title":"Internal Medicine"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0217|cit217","unstructured":"Feriani M The effect of balance PD solution on the peritoneal membrane in patients on automated peritoneal dialysis www.clinicaltrials.gov\/ct2\/show\/NCT01753154"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0218|cit218","first-page":"131","article-title":"The effect of icodextrin dialysis solution on selected metabolic parameters in patients on continuous ambulatory peritoneal dialysis (CAPD) [abstract]","author":"Opatrna","year":"2000","journal-title":"Kidney & Blood Pressure Research"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0219|cit219","first-page":"281","article-title":"Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis","volume":"141","author":"Opatrna","year":"2002","journal-title":"Casopis Lekaru Ceskych"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ndt\/gfr244","article-title":"Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study","volume":"27","author":"Rodriguez-Carmona","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub3-BIB0221|cit221","first-page":"199A","article-title":"Dependence of ultrafiltration response to icodextrin on peritoneal membrane transport type [abstract no: F-PO684]","volume":"13","author":"Yang","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0222|cit222","unstructured":"Ruzicka M Effects of non-glucose-based peritoneal dialysis solution \"extraneal\" on changes in leptin levels and sympathetic activity induced by conventional glucose-based dialysate \"dianeal\" in patients on peritoneal dialysis www.clinicaltrials.gov\/ct2\/show\/NCT01228279"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3747\/pdi.2010.00234","article-title":"Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan","volume":"32","author":"Ayuzawa","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"10","key":"10.1002\/14651858.CD007554.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub3-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/ndt\/gfq213","article-title":"Slouching towards Bethlehem: the beast of biocompatibility","volume":"25","author":"Bargman","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1523-1755.2002.00115.x","article-title":"AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression","volume":"61","author":"Boulanger","year":"2002","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/089686080902900602","article-title":"Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD","volume":"29","author":"Brown","year":"2009","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3747\/pdi.2017.00018","article-title":"Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD: 2017 update","volume":"37","author":"Brown","year":"2017","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"812609","DOI":"10.1155\/2012\/812609","article-title":"Biocompatible peritoneal dialysis fluids: clinical outcomes","volume":"2012","author":"Cho","year":"2012","journal-title":"International Journal of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1093\/ndt\/gfp313","article-title":"Preserving residual renal function in peritoneal dialysis: volume or biocompatibility?","volume":"24","author":"Davies","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7650","key":"10.1002\/14651858.CD007554.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD007554.pub3-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0234|cit234","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3747\/pdi.2016.00206","article-title":"Predictors of residual renal function decline in peritoneal dialysis patients: the balANZ trial","volume":"37","author":"Htay","year":"2017","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1797.2003.00117.x","article-title":"Recommendations for the use of icodextrin in peritoneal dialysis patients","volume":"8","author":"Johnson","year":"2003","journal-title":"Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD007554.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ki.2010.16","article-title":"Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes","volume":"77","author":"Johnson","year":"2010","journal-title":"Kidney International"},{"issue":"12","key":"10.1002\/14651858.CD007554.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1093\/ndt\/gfs314","article-title":"The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial","volume":"27","author":"Johnson","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/039139889201500203","article-title":"Biocompatibility of peritoneal dialysis fluids","volume":"15","author":"Jorres","year":"1992","journal-title":"International Journal of Artificial Organs"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1046\/j.1523-1755.1998.00178.x","article-title":"Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function","volume":"54","author":"Jorres","year":"1998","journal-title":"Kidney International"},{"issue":"1-3","key":"10.1002\/14651858.CD007554.pub3-BIB0241|cit241","first-page":"153-9","article-title":"Novel peritoneal dialysis solutions--what are the clinical implications?.[Erratum appears in Blood Purif. 2012;34(1):17]","volume":"33","author":"J\u00f6rres","year":"2012","journal-title":"Blood Purification"},{"issue":"8","key":"10.1002\/14651858.CD007554.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.2337\/diabetes.54.8.2424","article-title":"3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells","volume":"54","author":"Justo","year":"2005","journal-title":"Diabetes"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/ki.1995.244","article-title":"In vitro formation of advanced glycation end products in peritoneal dialysis fluid","volume":"47","author":"Lamb","year":"1995","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3747\/pdi.2015.00218","article-title":"Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure","volume":"36","author":"Lan","year":"2016","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrneph.2016.181","article-title":"Changes in the worldwide epidemiology of peritoneal dialysis","volume":"13","author":"Li","year":"2017","journal-title":"Nature Reviews Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub3-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"11","key":"10.1002\/14651858.CD007554.pub3-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/01.ASN.0000060681.91079.30","article-title":"Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane","volume":"14","author":"Mortier","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1523-1755.2004.00879.x","article-title":"Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane","volume":"66","author":"Mortier","year":"2004","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1523-1755.2005.00237.x","article-title":"Benefits of switching from a conventional to a low-GDP bicarbonate\/lactate-buffered dialysis solution in a rat model","volume":"67","author":"Mortier","year":"2005","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/089686080002004S02","article-title":"Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis","volume":"20 Suppl 4","author":"Mujais","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"11","key":"10.1002\/14651858.CD007554.pub3-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/ndt\/gfv132","article-title":"Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study","volume":"30","author":"Nadeau-Fredette","year":"2015","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.1997.22","article-title":"Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD","volume":"51","author":"Nakayama","year":"1997","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000450690","article-title":"Evidence for biocompatible peritoneal dialysis solutions","volume":"189","author":"Nataatmadja","year":"2017","journal-title":"Contributions to Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/089686089301300309","article-title":"Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes","volume":"13","author":"Nilsson-Thorell","year":"1993","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub3-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/039139880502800203","article-title":"Pathogenesis of peritoneal sclerosis","volume":"28","author":"Pollock","year":"2005","journal-title":"International Journal of Artificial Organs"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ndt\/13.1.154","article-title":"Sclerosing peritonitis: the experience in Australia","volume":"13","author":"Rigby","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1177\/089686089601601S24","article-title":"Effect of different buffers on the biocompatibility of CAPD solutions","volume":"16 Suppl 1","author":"Schambye","year":"1996","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0259|cit259","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0260|cit260","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semnephrol.2016.10.005","article-title":"Low GDP solution and glucose sparing strategies for peritoneal dialysis","volume":"37","author":"Szeto","year":"2017","journal-title":"Seminars in Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0262|cit262","first-page":"42","article-title":"In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions","volume":"17","author":"Topley","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"11-12","key":"10.1002\/14651858.CD007554.pub3-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0021-9681(75)90076-4","article-title":"Complications of acute peritoneal dialysis","volume":"28","author":"Vaamonde","year":"1975","journal-title":"Journal of Chronic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub3-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3747\/pdi.2014.00279","article-title":"ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients Part I - assessment and management of various cardiovascular risk factors","volume":"35","author":"Wang","year":"2015","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0265|cit265","first-page":"57","article-title":"Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid","volume":"12","author":"Wieslander","year":"1996","journal-title":"Advances in Peritoneal Dialysis"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0266|cit266","first-page":"S158-61","article-title":"Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions","volume":"84","author":"Williams","year":"2003","journal-title":"Kidney International - Supplement"},{"key":"10.1002\/14651858.CD007554.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/089686080502503S08","article-title":"Effects of peritoneal dialysis solutions on the peritoneal membrane: clinical consequences","volume":"25 Suppl 3","author":"Witowski","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"8","key":"10.1002\/14651858.CD007554.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2215\/CJN.05410514","article-title":"Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis","volume":"10","author":"Yohanna","year":"2015","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub3-BIB0269|cit269","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007554.pub2","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","author":"Cho","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub3-BIB0270|cit270","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","author":"Wiggins","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007554.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:53:30Z","timestamp":1775253210000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007554.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":270,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007554.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]}}}